Davide Ghinolfi
Overview
Explore the profile of Davide Ghinolfi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
382
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Angelico R, Trapani S, Manzia T, Lenci I, Grossi P, Ricci A, et al.
Am J Transplant
. 2025 Mar;
PMID: 40057194
Patients with HDV/HBV-related end-stage liver disease candidates for liver transplantation(LT) have traditionally been regarded as a special population, although their outcomes are controversial. A intention-to-treat(ITT) analysis of long-term outcomes of...
2.
Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrence
Burra P, Battistella S, Turco L, Morelli M, Frassanito G, De Maria N, et al.
JHEP Rep
. 2025 Mar;
7(3):101278.
PMID: 40041120
Background & Aims: Conflicting data exist regarding optimal prophylaxis for HBV recurrence (HBV-R) after liver transplantation (LT), particularly in patients with hepatocellular carcinoma (HCC). We assessed current practices for HBV-R...
3.
Balzano E, Bernardi L, Candita G, Trizzino A, Petagna L, Bozzi E, et al.
Life (Basel)
. 2025 Feb;
15(2).
PMID: 40003663
The management of de novo kidney tumors (DKTs) after liver transplantation (LT) is challenging due to previous transplant surgery and calcineurin inhibitors (CNI)-related nephrotoxicity. Minimally invasive renal-sparing strategies like robot-assisted...
4.
Cervelli R, Cencini M, Aringhieri G, Silvestrini B, Cacciato Insilla A, Campani D, et al.
Radiol Med
. 2025 Feb;
PMID: 39937367
Introduction: Hepatocellular carcinoma's (HCC) pathological grading is a recognized factor influencing intrahepatic recurrence after treatment. Thus, understanding the HCC heterogeneity is crucial to select the best treatment option aiming at...
5.
Lai Q, Melandro F, Vitale A, Ghinolfi D, Coubeau L, Pravisani R, et al.
Updates Surg
. 2025 Feb;
PMID: 39928277
Liver transplantation (LT) is the primary treatment for selected patients with hepatocellular carcinoma (HCC). However, HCC-related mortality post-LT remains a significant concern, with up to 10% of cases reported in...
6.
Pezzati D, Torri F, Franzini M, Balzano E, Catalano G, Tincani G, et al.
Liver Transpl
. 2025 Feb;
PMID: 39927817
Background: The use of the so-called extended criteria donors increases the number of grafts available for transplantation. Many studies reported their good outcomes but their use is debated due to...
7.
Bernardi L, Balzano E, Roesel R, Senatore A, Pezzati D, Catalano G, et al.
Surg Endosc
. 2025 Feb;
39(3):2116-2128.
PMID: 39904789
Background: Robotic (RLR) and laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) provide similar short-term outcomes, but data focused on recurrence and survival are still lacking. We hypothesized non-inferior oncologic...
8.
Basta G, Babboni S, Pezzati D, Del Turco S, Balzano E, Catalano G, et al.
Biomedicines
. 2025 Jan;
13(1).
PMID: 39857827
: The rising use of liver grafts from donation after circulatory death (DCD) has been enabled by advances in normothermic regional perfusion (NRP) and machine perfusion (MP) technologies. We aimed...
9.
Gitto S, Fiorillo C, Argento F, Fini E, Borghi S, Falcini M, et al.
Res Pract Thromb Haemost
. 2024 Sep;
8(6):102555.
PMID: 39309232
Background: Cardiovascular events represent a major cause of non-graft-related death after liver transplant. Evidence suggest that chronic inflammation associated with a remarkable oxidative stress in the presence of endothelial dysfunction...
10.
De Carlis R, Lauterio A, Schlegel A, Gringeri E, Patrono D, Camagni S, et al.
Liver Transpl
. 2024 Sep;
31(1):70-84.
PMID: 39287560
Dual hypothermic oxygenated perfusion (DHOPE) is increasingly being used to extend liver preservation to improve transplant logistics. However, little is known about its benefits in high-risk liver grafts. This study...